Bend, OR, United States of America

Mark B Chidlaw


Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1996-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Mark B Chidlaw

Introduction

Mark B Chidlaw is an accomplished inventor based in Bend, Oregon. He has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. His innovative approaches focus on controlled release dosage forms that enhance the efficacy of medications.

Latest Patents

Chidlaw's latest patents include the "Hydrogel-driven drug dosage form" and the "Hydrogel-driven layered drug dosage form." The first patent describes a controlled release dosage form featuring a coated core that contains both a drug-containing composition and a water-swellable composition. This design allows for a variety of formulations with specific drug release profiles. The second patent focuses on a controlled release dosage form specifically for sertraline, detailing a unique core composition and a coating that regulates the release of the drug over time.

Career Highlights

Throughout his career, Mark B Chidlaw has worked with notable companies such as Sartorius AG and Pfizer Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and drug delivery technologies.

Collaborations

Chidlaw has collaborated with professionals like Dwayne Thomas Friesen and William John Curatolo, further enhancing his work in the field of drug delivery systems.

Conclusion

Mark B Chidlaw's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a significant inventor in drug delivery technologies. His work continues to influence the development of effective medication delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…